X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4505) 4505
Publication (711) 711
Book Chapter (40) 40
Conference Proceeding (30) 30
Book Review (28) 28
Book / eBook (11) 11
Web Resource (8) 8
Dissertation (7) 7
Data Set (2) 2
Magazine Article (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2698) 2698
index medicus (2160) 2160
animals (1965) 1965
proprotein convertases (1541) 1541
biochemistry & molecular biology (1164) 1164
male (1033) 1033
mice (1021) 1021
proprotein convertase 9 (911) 911
female (891) 891
amino acid sequence (708) 708
cholesterol (707) 707
molecular sequence data (698) 698
furin (681) 681
serine endopeptidases - genetics (663) 663
serine endopeptidases - metabolism (604) 604
pcsk9 (560) 560
proprotein convertases - metabolism (551) 551
cholesterol, ldl - blood (529) 529
hypercholesterolemia (524) 524
middle aged (510) 510
cell biology (508) 508
mutation (488) 488
expression (481) 481
proprotein convertase (457) 457
endocrinology & metabolism (456) 456
proprotein convertases - genetics (450) 450
subtilisins - metabolism (443) 443
rats (428) 428
low density lipoproteins (415) 415
familial hypercholesterolemia (405) 405
lipids (404) 404
cardiac & cardiovascular systems (400) 400
cell line (400) 400
protein processing, post-translational (394) 394
adult (378) 378
proteins (377) 377
research (361) 361
atherosclerosis (356) 356
proprotein convertase 9 - antagonists & inhibitors (348) 348
proprotein convertases - antagonists & inhibitors (342) 342
protein precursors - metabolism (337) 337
statins (336) 336
aged (322) 322
identification (314) 314
proprotein convertase 2 (314) 314
risk factors (301) 301
peripheral vascular disease (298) 298
analysis (296) 296
base sequence (292) 292
subtilisins - genetics (292) 292
pharmacology & pharmacy (290) 290
hypercholesterolemia - drug therapy (288) 288
anticholesteremic agents - therapeutic use (285) 285
genetic aspects (283) 283
antibodies, monoclonal - therapeutic use (280) 280
proprotein convertase subtilisin/kexin type 9 (280) 280
receptors, ldl - metabolism (280) 280
cells (278) 278
article (272) 272
subtilisin/kexin type 9 (272) 272
saccharomyces cerevisiae proteins (269) 269
monoclonal-antibody (264) 264
gene expression (263) 263
gene (261) 261
activation (260) 260
physiological aspects (260) 260
receptors, ldl - genetics (252) 252
ldl cholesterol (249) 249
cardiovascular disease (245) 245
mutations (240) 240
density-lipoprotein cholesterol (238) 238
enzymes (232) 232
cardiovascular (225) 225
abridged index medicus (222) 222
lipoproteins (222) 222
rna, messenger - metabolism (222) 222
transfection (222) 222
autosomal-dominant hypercholesterolemia (217) 217
coronary-heart-disease (217) 217
cleavage (216) 216
mice, knockout (210) 210
subtilisin (209) 209
research article (207) 207
prohormone convertases (204) 204
treatment outcome (204) 204
furin - metabolism (203) 203
gene-expression (203) 203
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (203) 203
heterozygous familial hypercholesterolemia (202) 202
substrate specificity (202) 202
cells, cultured (197) 197
protein (193) 193
ldl receptor (192) 192
risk (192) 192
hyperlipoproteinemia type ii - genetics (190) 190
proprotein convertase 9 - metabolism (190) 190
multidisciplinary sciences (189) 189
proteases (189) 189
low density lipoprotein (188) 188
proprotein convertase 9 - genetics (188) 188
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4393) 4393
German (46) 46
Spanish (22) 22
Chinese (16) 16
Japanese (14) 14
French (13) 13
Czech (11) 11
Russian (9) 9
Italian (8) 8
Hungarian (5) 5
Polish (5) 5
Turkish (4) 4
Swedish (2) 2
Croatian (1) 1
Danish (1) 1
Korean (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2006, ISBN 9781402047930, x, 157
Convertases are widely expressed activating enzymes involved in various physiological and pathological processes. This book provides detailed and updated... 
Treatment | Enzyme inhibitors | Genetic aspects | Carcinogenesis | Molecular aspects | Therapeutic use | Cancer | Cancer Research | Oncology | Biomedicine | Chemistry/Food Science, general
Book
2011, Methods in molecular biology, ISBN 1617792039, Volume 768., xi, 367
Book
Circulation, ISSN 0009-7322, 08/2013, Volume 128, Issue 9, pp. 962 - 969
Journal Article
Circulation, ISSN 0009-7322, 11/2012, Volume 126, Issue 20, pp. 2408 - 2417
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 07/2015, Volume 163, Issue 1, pp. 40 - 51
Journal Article
2011, Methods in molecular biology, ISBN 1617792039, Volume 768
Web Resource
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2003, Volume 100, Issue 3, pp. 928 - 933
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9911, pp. 60 - 68
Summary Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to LDL receptors, leading to their degradation. Genetics studies have shown that... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | DOUBLE-STRANDED-RNA | PLASMA-CHOLESTEROL | METAANALYSIS | CARDIOVASCULAR-DISEASE | MONOCLONAL-ANTIBODY | HYPERCHOLESTEROLEMIA | STATINS | AMG 145 | ATORVASTATIN | Single-Blind Method | Serine Endopeptidases - biosynthesis | Humans | Middle Aged | RNA, Small Interfering - pharmacology | RNA, Small Interfering - adverse effects | Cholesterol, LDL - drug effects | Male | Healthy Volunteers | Proprotein Convertases - genetics | Dose-Response Relationship, Drug | Proprotein Convertases - biosynthesis | RNA Interference | Serine Endopeptidases - blood | Serine Endopeptidases - genetics | Adult | Cholesterol, LDL - blood | Female | Proprotein Convertases - blood | RNA, Small Interfering - administration & dosage | Genetic Therapy - adverse effects | Genetic Therapy - methods | Proprotein Convertase 9 | Enzymes | Research | Gene mutations | Properties | Gene expression | Identification and classification | Medical research | RNA | Low density lipoproteins | Anticholesteremic agents | Clinical trials | Aluminum compounds | Coronary heart disease | Cholesterol | Hypercholesterolemia | Analysis | Medicine, Experimental | Product development | Trans fatty acids | Blood proteins | Studies | Heart | Nanoparticles | Plasma | Nutrition research | Cardiovascular disease | Lipids | Mutation | Drug dosages | Statins
Journal Article
Circulation, ISSN 0009-7322, 10/2015, Volume 132, Issue 17, pp. 1648 - 1666
Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays an important role in the regulation of cholesterol homeostasis. By binding to hepatic low-density... 
Antibodies, monoclonal | Clinical trial | PCSK9 protein, human | antibodies, monoclonal | clinical trial | CARDIAC & CARDIOVASCULAR SYSTEMS | LOWERING THERAPY | MONOCLONAL-ANTIBODY | DENSITY-LIPOPROTEIN-CHOLESTEROL | HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | DOUBLE-BLIND | PERIPHERAL VASCULAR DISEASE | STATIN-INTOLERANT PATIENTS | HEALTHY-VOLUNTEERS | CORONARY-HEART-DISEASE | PLASMA LDL CHOLESTEROL | PCSK9 GENE | Proprotein Convertases - antagonists & inhibitors | Cardiovascular Diseases - prevention & control | Humans | Serine Endopeptidases - physiology | Antibodies, Monoclonal - therapeutic use | Intestines - metabolism | Structure-Activity Relationship | Cardiovascular Diseases - enzymology | Molecular Targeted Therapy | Cardiovascular Diseases - genetics | Proprotein Convertases - genetics | Incidence | Brain - metabolism | RNA Interference | Oligonucleotides, Antisense - therapeutic use | Serine Endopeptidases - genetics | Cardiovascular Diseases - epidemiology | Protein Structure, Tertiary | Genetic Predisposition to Disease | Antibodies, Monoclonal, Humanized - therapeutic use | Serine Endopeptidases - deficiency | Liver - metabolism | Receptors, LDL - metabolism | Serine Endopeptidases - chemistry | Clinical Trials as Topic | Proprotein Convertases - chemistry | Proprotein Convertases - deficiency | Proprotein Convertases - physiology | Animals | RNA, Small Interfering - therapeutic use | Adipocytes - metabolism | Cholesterol, LDL - metabolism | Hyperlipoproteinemias - genetics | Mice | Peptide Fragments - therapeutic use | Mutation | Proprotein Convertase 9 | Monoclonal antibodies | Clinical trials | Usage | Care and treatment | Dosage and administration | Cardiovascular diseases
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9858, pp. 2007 - 2017
Journal Article
Journal Article
Journal Article